PriceSensitive

Datametrex (TSXV:DM) signs two new feature films in Montreal

Health Care, Market News
TSXV:DM
30 August 2021 09:00 (EDT)

Datametrex AI Limited (DM) has signed two new service agreements for COVID-19 testing with two Hollywood feature-length films in Montreal.

Film and TV productions in Canada including unions representing production staff, film crews and actors along with Canadians in general, have a foremost concern regarding the Delta variant (B.1.617.2. variant), a hyper-contagious SARS-CoV-2 virus strain, which was first identified in India in October 2020.

Datametrex will continue to provide COVID-19 testing kits for actors, film crews, and production support staff to prevent cluster outbreaks. Film and TV production companies all support the continued use of safety protocols, especially COVID-19 testing to keep production members and actors healthy and safe while employed on sets and in production offices.

“The COVID-19 testing market in Montreal and across our network is an important business segment for Datametrex and we look to remain steadfast is supporting the film industry with COVID testing and now with the Delta variant of the virus now the dominant variant worldwide, it is right time to continue testing protocols to keep everyone working and continuing to stay healthy,” stated Marshall Gunter, CEO of Datametrex.

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence and machine learning through its wholly-owned subsidiary, Nexalogy. Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies.

Datametrex AI Limited (DM) opened trading at C$0.185 per share.

Related News